Perfil de la empresa · Healthcare

Progyny Inc

PGNY · EE. UU.
País / Región
USA
Fecha de salida a bolsa
25 de octubre de 2019
Empleados
835
Buffett Score
43/100
Floja
Capitalización1935,82 M US$
Ingresos (TTM)1310,76 M US$
EBITDA125,57 M US$
Margen neto6 %
ROE16,24 %
PER (TTM)27,42
PER previsto11,85
BPA0,92 US$
Rango de 52 semanas16,10 US$ – 33,07 US$
Precio objetivo de analistas34,42 US$
Recomendación de analistas4.6 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.